OBO_ID (LABEL):	CHEBI_15843 (arachidonic acid)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
BMJ_2012_Jan_30_344_e184	1/2012	S14-BMJ_2012_Jan_30_344_e184	['Arachidonic Acid gives rise to Eicosanoids such as Prostaglandin E2, which can enhance the synthesis of T Helper type 2 cytokines and Immunoglobulin e Antibodiesâ€”the hallmark of Atopic Responses To Allergens.']	N/A	N/A	[('CHEBI_15843', 'arachidonic acid', 0, 'Arachidonic acid'), ('CHEBI_36744', 'guaiane sesquiterpenoid', 31, 'eicosanoids'), ('CHEBI_15551', 'prostaglandin E2', 51, 'prostaglandin E2'), ('CL_0002061', 'T-helper 9 cell', 104, 'T helper'), ('GO_0019814', 'immunoglobulin complex', 134, 'immunoglobulin'), ('GO_0042571', 'immunoglobulin complex, circulating', 151, 'antibodies'), ('GO_1990375', 'baculum development', 178, 'atopic responses to allergens'), ('CHEBI_33663', 'cyclic hydrocarbon', 198, 'allergens')]
PMC3543392	12/2012	S217-PMC3543392	['abbreviations\nala: Linolenic Acid; ara: Arachidonic Acid; bp: Blood pressure; cad: Coronary Artery disease; cefa: Cholesterol Ester Fatty Acid; cvd: Cardiovascular diseases; Dha: Docosahexaenoic Acid; disc: dietary interventio dietary intervention study in children; dbp: diastolic bp; espghan: european society of pediatric Gastroenterology hepatology and nutrition; Epa: Eicosapentaenoic Acid; foad: fetal origins of Adult disease; Hdl-C: High-density Lipoprotein Cholesterol; Hmg-Coa: Hydroxymethylglutaril Coenzyme A; Igf-1: Insulin Growth Factor 1; ir: Insulin resistance; La: Linoleic Acid; lbw: low Birthweight; lcpufa: Long Chain polyunsaturated Fatty Acids; ldl-c: low-density lipoprotein Cholesterol; mufa: monounsaturated Fatty Acid; ms: Metabolic syndrome; pufa: polyunsaturated Fatty Acids; sbp: systolic bp; strip: special turku Coronary risk factor intervention project; tc: total Cholesterol; t2dm: type 2 diabetes mellitus; tg: Triglycerides; who: world health organization.']	N/A	N/A	[('CHEBI_16494', 'lipoic acid', 19, 'Linolenic acid'), ('CHEBI_15843', 'arachidonic acid', 40, 'Arachidonic acid'), ('UBERON_0000178', 'blood', 62, 'Blood'), ('UBERON_0001621', 'coronary artery', 83, 'Coronary artery'), ('CHEBI_82381', '5-Aminoacenaphthene', 114, 'Cholesterol ester fatty acid'), ('UBERON_0004535', 'cardiovascular system', 149, 'Cardiovascular'), ('CHEBI_17874', 'dihydrozeatin', 174, 'DHA'), ('CHEBI_78869', 'octacosapentaenoic acid', 179, 'Docosahexaenoic acid'), ('UBERON_0010898', 'gastralium', 325, 'gastroenterology'), ('CHEBI_34733', 'EPN', 368, 'EPA'), ('CHEBI_31001', 'octacosanoic acid', 373, 'Eicosapentaenoic acid'), ('UBERON_0007023', 'adult organism', 419, 'adult'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 434, 'HDL-C'), ('PR_000008466', 'hepatitis B virus X-interacting protein', 441, 'High'), ('PR_000009893', 'acyl-CoA:lysophosphatidylglycerol acyltransferase 1', 454, 'lipoprotein'), ('CHEBI_16113', 'cholesterol', 466, 'cholesterol'), ('CHEBI_17883', 'hydrogen chloride', 479, 'HMG'), ('CHEBI_15346', 'coenzyme A', 483, 'CoA'), ('CHEBI_15729', 'L-ornithine', 488, 'Hydroxymethylglutaril coenzyme A'), ('PR_000008929', 'interferon-related developmental regulator 1', 522, 'IGF-1'), ('PR_000008929', 'interferon-related developmental regulator 1', 529, 'Insulin growth factor 1'), ('PR_000045358', 'insulin family protein', 558, 'Insulin'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 578, 'LA'), ('CHEBI_16494', 'lipoic acid', 582, 'Linoleic acid'), ('GO_0007596', 'blood coagulation', 606, 'birthweight'), ('CHEBI_6541', 'losartan', 627, 'Long chain'), ('CHEBI_35366', 'fatty acid', 654, 'fatty acids'), ('CHEBI_16113', 'cholesterol', 698, 'cholesterol'), ('CHEBI_35366', 'fatty acid', 733, 'fatty acid'), ('GO_0008152', 'metabolic process', 749, 'Metabolic'), ('CHEBI_35366', 'fatty acid', 791, 'fatty acids'), ('UBERON_0005985', 'coronary vessel', 843, 'coronary'), ('CHEBI_16113', 'cholesterol', 896, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 945, 'Triglycerides')]
PMC4701936	1/2016	S225-PMC4701936	['Arachidonic Acid (20:4n-6), the precursor of the Aea and 2-Ag, derives from dietary Linoleic Acid (18:2n-6), and it is reduced in the Brain of the free-choice group offspring.']	N/A	N/A	[('CHEBI_15843', 'arachidonic acid', 0, 'Arachidonic acid'), ('CHEBI_39048', 'ADA', 49, 'AEA'), ('CHEBI_51383', 'hydridocarbon(3.)', 57, '2-AG'), ('CHEBI_30881', 'xanthine-8-carboxylic acid', 84, 'linoleic acid'), ('UBERON_0000955', 'brain', 134, 'brain')]
PMC4934568	10/2014	S78-PMC4934568	['also, Folic Acid is an Inhibitor of dhfr in reduction of its substrate 7,8 Dihydrofolic Acid.']	N/A	N/A	[('CHEBI_30751', 'formic acid', 6, 'folic acid'), ('CHEBI_35222', 'inhibitor', 23, 'inhibitor'), ('CHEBI_15843', 'arachidonic acid', 71, '7,8 dihydrofolic acid')]
PMC4989298	8/2016	S253-PMC4989298	['Arachidonic Acid it is the predominant precursor, present in high concentrations in all Membrane Phospholipids.']	N/A	N/A	[('CHEBI_15843', 'arachidonic acid', 0, 'Arachidonic acid'), ('GO_0016020', 'membrane', 88, 'membrane'), ('CHEBI_16247', 'phospholipid', 97, 'phospholipids')]
PMC5088205	11/2016	S188-PMC5088205	['(a) Anandamide (Aea), (b) Arachidonoylglycerol (2-Ag), (c) Arachidonic Acid (aa), (d) Oleoylethanolamide (oea), and (e) Palmitoylethanolamide (Pea) in the Hypothalamus of male offspring from control dams (open bars) and calorie-restricted dams (solid bars) at Birth.']	N/A	N/A	[('CHEBI_2704', 'anastrozole', 4, 'Anandamide'), ('CHEBI_39048', 'ADA', 16, 'AEA'), ('CHEBI_76580', 'Mono-(alk-1-enyl)-glycerol', 26, 'arachidonoylglycerol'), ('CHEBI_51383', 'hydridocarbon(3.)', 48, '2-AG'), ('CHEBI_15843', 'arachidonic acid', 59, 'Arachidonic acid'), ('CHEBI_71466', 'oleoyl ethanolamide', 86, 'oleoylethanolamide'), ('CHEBI_71464', 'palmitoyl ethanolamide', 120, 'palmitoylethanolamide'), ('CHEBI_39015', 'apolipoprotein', 143, 'PEA'), ('UBERON_0001898', 'hypothalamus', 155, 'hypothalamus'), ('GO_0007567', 'parturition', 260, 'birth')]
PMC5088205	11/2016	S195-PMC5088205	['(a) Anandamide (Aea), (b) Arachidonoylglycerol (2-Ag), (c) Arachidonic Acid (aa), (d) Oleoylethanolamide (oea), and (e) Palmitoylethanolamide (Pea) in the hippocampus of male offspring from control dams (open bars) and calorie-restricted dams (solid bars) at Birth.']	N/A	N/A	[('CHEBI_2704', 'anastrozole', 4, 'Anandamide'), ('CHEBI_39048', 'ADA', 16, 'AEA'), ('CHEBI_76580', 'Mono-(alk-1-enyl)-glycerol', 26, 'arachidonoylglycerol'), ('CHEBI_51383', 'hydridocarbon(3.)', 48, '2-AG'), ('CHEBI_15843', 'arachidonic acid', 59, 'Arachidonic acid'), ('CHEBI_71466', 'oleoyl ethanolamide', 86, 'oleoylethanolamide'), ('CHEBI_71464', 'palmitoyl ethanolamide', 120, 'palmitoylethanolamide'), ('CHEBI_39015', 'apolipoprotein', 143, 'PEA'), ('GO_0007567', 'parturition', 259, 'birth')]
PMC5088205	11/2016	S202-PMC5088205	['(a) Anandamide (Aea), (b) Arachidonoylglycerol (2-Ag), (c) Arachidonic Acid (Aa) and (d) Palmitoylethanolamide (pea) in the Olfactory Bulb of male offspring from control dams (open bars) and calorie-restricted dams (solid bars) at Birth.']	N/A	N/A	[('CHEBI_2704', 'anastrozole', 4, 'Anandamide'), ('CHEBI_39048', 'ADA', 16, 'AEA'), ('CHEBI_76580', 'Mono-(alk-1-enyl)-glycerol', 26, 'arachidonoylglycerol'), ('CHEBI_51383', 'hydridocarbon(3.)', 48, '2-AG'), ('CHEBI_15843', 'arachidonic acid', 59, 'Arachidonic acid'), ('CHEBI_27718', "alpha-Fuc-(1->2)-[alpha-Fuc-(1->2)-beta-Gal-(1->3)-alpha-GalNAc-(1->3)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer", 77, 'AA'), ('CHEBI_71464', 'palmitoyl ethanolamide', 89, 'palmitoylethanolamide'), ('GO_0007608', 'sensory perception of smell', 124, 'olfactory'), ('UBERON_0002264', 'olfactory bulb', 124, 'olfactory bulb'), ('GO_0007567', 'parturition', 231, 'birth')]
